These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 11925775)

  • 1. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer--certitudes and hypotheses.
    Amihăesei IC; Cojocarut E; Mungiu OC
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(1):119-26. PubMed ID: 24505903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Melatonin and Neurotransmission in Alzheimer's Disease.
    Roy J; Tsui KC; Ng J; Fung ML; Lim LW
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles.
    Andrade-Moraes CH; Oliveira-Pinto AV; Castro-Fonseca E; da Silva CG; Guimarães DM; Szczupak D; Parente-Bruno DR; Carvalho LR; Polichiso L; Gomes BV; Oliveira LM; Rodriguez RD; Leite RE; Ferretti-Rebustini RE; Jacob-Filho W; Pasqualucci CA; Grinberg LT; Lent R
    Brain; 2013 Dec; 136(Pt 12):3738-52. PubMed ID: 24136825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathogenesis of Alzheimer's disease: molecular and cellular mechanisms].
    Govaerts L; Schoenen J; Bouhy D
    Rev Med Liege; 2007 Apr; 62(4):209-16. PubMed ID: 17566391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging concepts in Alzheimer's disease.
    Vinters HV
    Annu Rev Pathol; 2015; 10():291-319. PubMed ID: 25387055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
    Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease.
    Beffert U; Poirier J
    Ann N Y Acad Sci; 1996 Jan; 777():166-74. PubMed ID: 8624080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
    Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
    Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
    Takahashi RH; Nagao T; Gouras GK
    Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel presenilin-1 mutation with widespread cortical amyloid deposition but limited cerebral amyloid angiopathy.
    Yasuda M; Maeda S; Kawamata T; Tamaoka A; Yamamoto Y; Kuroda S; Maeda K; Tanaka C
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):220-3. PubMed ID: 10644793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of Alzheimer's disease: a critical update.
    Jellinger KA; Bancher C
    J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.
    Wilcock DM
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):386-94. PubMed ID: 20522016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.